Cargando…
A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors
OBJECTIVE: For early-stage cervical cancer patients experiencing radical surgery, postoperative radiotherapy was recommended for patients with a combination of intermediate-risk factors. However, there was no consensus on whether to administer concurrent chemotherapy. The aim of the study was to con...
Autores principales: | Fu, Chunli, Wang, Cong, Qian, Qiuhong, Zhang, Youzhong, Ma, Changdong, Miao, Li, Zhang, Guangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300080/ https://www.ncbi.nlm.nih.gov/pubmed/37389134 http://dx.doi.org/10.1016/j.gore.2023.101228 |
Ejemplares similares
-
Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy
por: Zhang, Guangyu, et al.
Publicado: (2021) -
A Novel Risk Factor for Para-Aortic
Lymph Node Recurrence After Definite
Pelvic Radiotherapy in Stage IIIB
Cervical Cancer
por: Zhang, Guangyu, et al.
Publicado: (2022) -
Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer
por: Zhang, Guangyu, et al.
Publicado: (2014) -
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
por: Weng, Danhui, et al.
Publicado: (2022) -
Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
por: Yu, Hao, et al.
Publicado: (2016)